Ai Progetti Ordinari del Programma straordinario per la ricerca oncologica sono state riservate, in prima istanza, risorse pari al 30% (21 milioni di euro) del fondo complessivo (70 milioni di euro) messo a disposizione per il Bando della ricerca oncologica.

Regione CampaniaDetection of cancer-causing mutations by innovative high-throughput technological platforms165.000,00
Regione CampaniaMolecular diagnostic and prognostic markers of thyroid neoplasias504.000,00
Regione Emilia RomagnaBiological predictive factors of response to target therapies in lung cancer296.000,00
Regione Emilia RomagnaBiomarkers discovery for the early diagnosis and for proteomic classification of Hepatocellular Carcinoma837.000,00
Regione Emilia RomagnaCharacterization of normal and neoplastic hematopoietic stem cells for the clinical use for tissue regeneration and the development of novel anti-tumor targeted therapies220.000,00
Regione Emilia RomagnaPost-genomic approaches for the identification of highrisk cancers: evaluation and optimization of costs/benefits for the National Health System462.000,00
Regione LiguriaHereditary, molecular and environmental factors in the pancreatic cancer early diagnosis248.000,00
Regione LiguriaIdentification of tumor biomarkers through a biologydriven integrated approach498.000,00
Regione LombardiaHumanization of cancer care in Italy: implementation of evidence-based recommendations (HUCARE project)544.000,00
Regione LombardiaUse of integrated PET/CT as a first line re-staging technique in oncological patients316.000,00
Regione SiciliaMolecular mechanisms controlling cancer stem cells survival1.239.000,00
Regione UmbriaMulticentric randomized study comparing gefitinib versus platinum-based chemotherapy in EGFR fish positive NSCLC patients120.000,00
Regione VenetoIdentification of novel molecular targets in pancreatic cancer by analysis of tumor-stroma interaction148.000,00
Regione VenetoSignalling Molecules as Targets for New Antineoplastic Strategies300.000,00
Istituto neurologico Carlo Besta - MilanoEpigenetics and post-transcriptional regulation in cancer stem-like cells from glioblastoma multiforme314.000,00
Istituto neurologico Carlo Besta - MilanoRole of Brain Mapping in the surgical treatment of low grade gliomas578.000,00
Casa sollievo della sofferenza - San Giovanni RotondoHRPT2 gene and the WNT pathway: new insights in the genetics of parathyroid and biliary ducts carcinomas385.000,00
Istituto Giannina Gaslini - GenovaHealth status of adults survivors of childhood cancer400.000,00
Istituto Giannina Gaslini - GenovaNew Immunotherapeutic Approaches to Neuroblastoma740.000,00
Istituto clinico Humanitas - AnconaInnate immunity and gastrointestinal cancer as paradigm: from new molecules to the bed side703.000,00
Istituto Oncologico Veneto - PadovaAngiogenesis at the interface between tumor and microenvironment: biological studies and therapeutic implications in haematologic malignancies374.000,00
Istituto Europeo di Oncologia - MilanoBiological and molecular characterization of cancer stem cells895.000,00
Istituto Europeo di Oncologia - MilanoSurrogate markers of antiangiogenic therapy in triple receptor negative breast cancer295.000,00
Istituto nazionale per la ricerca sul cancro - GenovaTargeting tumor-related immunosuppression for new combined approaches of immunotherapy340.000,00
Istituto Dermopatico dell'Immacolata - RomaAntivascular therapy in melanoma: from preclinical to clinical studies809.000,00
Istituto Dermopatico dell'Immacolata - RomaMolecular characterization of melanoma cancer stem cells950.000,00
Istituto nazionale dei tumori - MilanoControlled Extension of Conventional Criteria for Liver Transplantation in Hepatocarcinoma (HCC): a prospective validation study315.000,00
Istituto nazionale dei tumori - MilanoTumor radioresistance and predictive markers of the response to radiotherapy310.000,00
Centro cardiologico Monzino - MilanoCharacterization of molecules involved in tumor angiogenesis regulation835.000,00
Istituto nazionale tumori Fondazione PascalePyrrolo benzothiadiazepines as new agents for targeting tumor and stromal cell populations in multiple myeloma and chronic lymphocytic leukemia505.000,00
Istituti ortopedici Rizzoli - BolognaGenes regulating osteoblastogenesis as new therapeutic targets for bone tumors325.000,00
Istituto dermatologico San Gallicano - RomaCell signaling in human melanoma: identification of genetic and epigenetic mechanism potentially relevant for clinical management389.000,00
Policlinico San Matteo - PaviaIdentification of new histologic, phenotypic and molecular types of gastric cancer for prognosis predictive classification, early diagnosis and improved therapy225.000,00
Fondazione San Raffaele del Monte Tabor - MilanoNew murine models of tumors: new avenues for the identification of novel oncogenes and therapeutic strategies999.000,00
Istituto nazionale per le malattie infettive Spallanzani - RomaNeoangiogenesis in hepatoma and other tumors: novel therapeutical targeting of endothelial precursors880.000,00
Istituto Superiore di SanitàIdentification and therapeutic targeting of new oncogenetic molecules in human tumors: basic, preclinical and clinical studies692.000,00
Istituto Superiore di SanitàNew therapeutic strategies based on studies of tumor microenvironment and new targets identified through proteomic and genomic profile analysis1.073.000,00
Istituto Superiore di SanitàUse of HIV protease inhibitors to block HIV negative cervical cancer progression and recurrence1.260.000,00
Istituto Superiore per la Prevenzione e Sicurezza sul LavoroNovel approaches to assess the carcinogenic potential of genotoxic pollutants326.000,00
Istituto Zooprofilattico Sperimentale della SiciliaVaccination against spontaneous canine breast carcinomas with an experimental DNA vaccine (immunization against the proto-oncogene Her-2/neu)186.000,00
TOTALE 21.000.000


  • Condividi
  • Stampa
  • Condividi via email

Data di pubblicazione: 16 giugno 2008, ultimo aggiornamento 11 luglio 2013

Pubblicazioni   |   Opuscoli e poster   |   Normativa   |   Home page dell'area tematica Torna alla home page dell'area